These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

872 related items for PubMed ID: 11961504

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M, Kodama T.
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [Abstract] [Full Text] [Related]

  • 3. Chemoprevention of breast cancer.
    O'Regan RM.
    Cancer Treat Res; 2000; 103():183-207. PubMed ID: 10948447
    [No Abstract] [Full Text] [Related]

  • 4. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.
    Lee WL, Cheng MH, Chao HT, Wang PH.
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):24-31. PubMed ID: 18400579
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Two good choices to prevent breast cancer: great taste, less filling.
    Hortobagyi GN, Brown PH.
    Cancer Prev Res (Phila); 2010 Jun; 3(6):681-5. PubMed ID: 20522797
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tamoxifen, screening and new oestrogen receptor modulators.
    Neven P, Vergote I.
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):365-80. PubMed ID: 11476559
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Breast cancer chemoprevention. Rational, trials results and future].
    Cutuli B, Lesur A, Namer M, Kerbrat P.
    Bull Cancer; 2009 May; 96(5):519-30. PubMed ID: 19467983
    [Abstract] [Full Text] [Related]

  • 13. Chemoprevention of breast cancer: recommendations and rationale.
    Berg AO, U.S. Preventive Services Task Force.
    Am J Nurs; 2003 May; 103(5):107, 109, 111, 113. PubMed ID: 12759615
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Selective estrogen-receptor modulators (SERM's) in postmenopausal women].
    Hart W, Netelenbos JC.
    Ned Tijdschr Geneeskd; 1999 Aug 28; 143(35):1771-6. PubMed ID: 10494328
    [Abstract] [Full Text] [Related]

  • 16. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
    Lee WL, Chao HT, Cheng MH, Wang PH.
    Maturitas; 2008 Jun 20; 60(2):92-107. PubMed ID: 18534794
    [Abstract] [Full Text] [Related]

  • 17. Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health.
    Goldstein SR.
    Int J Fertil Womens Med; 1999 Jun 20; 44(5):221-6. PubMed ID: 10569450
    [Abstract] [Full Text] [Related]

  • 18. [Selective estrogen receptors modulators (SERMs): biochemistry, pharmacology, and clinical use in gynecology].
    Terán Dávila J, Teppa Garrán AD.
    Ginecol Obstet Mex; 2005 Aug 20; 73(8):424-35. PubMed ID: 16304968
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.
    Jordan VC.
    J Med Chem; 2003 Mar 27; 46(7):1081-111. PubMed ID: 12646017
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.